Jawaid, Imran http://orcid.org/0000-0002-3548-3263
Saunders, Kathryn http://orcid.org/0000-0002-9289-5731
Hammond, Christopher J. http://orcid.org/0000-0002-3227-2620
Dahlmann-Noor, Annegret http://orcid.org/0000-0002-7402-4350
Bullimore, Mark A. http://orcid.org/0000-0002-6315-3720
Article History
Received: 12 March 2023
Revised: 5 July 2023
Accepted: 25 August 2023
First Online: 16 September 2023
Competing interests
: IJ is Co-PI for Ocumension. Advisory Board Santen and Altacor. Speaker fees for Novartis and Thea Pharmaceuticals. KS has received research funding from Nevakar, Vyluma and Hoya vision. AD-N is PI NEVAKAR CHAMP, CHAMP-UK, Ocumension and Myopia-X clinical trials, Advisory boards Santen Inc, SightGlass Vision, Novartis, Thea. ECP educational events and material Santen, CooperVision, Zeiss. Parent focus groups Novartis. Mark Bullimore is a consultant for Alcon Research, Bruno vision care, CooperVision, CorneaGen, EssilorLuxottica, Eyenovia, Genentech, Johnson & Johnson Vision, Lentechs, Novartis, Oculus, Paragon Vision Sciences, and Vyluma.